# Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

> **NCT06878274** · PHASE2 · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 118 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Stage III Lung Cancer

## Interventions

- **RADIATION:** Post-operative radiotherapy

## Key facts

- **NCT ID:** NCT06878274
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2030-02
- **Final completion:** 2032-02
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06878274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06878274, "Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06878274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*